Dr. Joyce
van den Berg
I combine patient care with academic research into the treatment of early pregnancy loss. My aim: clear, personal care, grounded in evidence.
From Alkmaar to Deventer
A snapshot of my work experience. The full timeline is on the About me page.
- 2025–present
Gynaecologist, Deventer Hospital
Staff gynaecologist, focus on reproductive medicine & benign gynaecology.
- 2024–2025
Ziekenhuis Gelderse Vallei, Ede
Residency in obstetrics & gynaecology (continued).
- 2021–2024
Radboudumc, Nijmegen
Residency, obstetrics & gynaecology.
- 2018–2021
Ziekenhuis Gelderse Vallei, Ede
Residency in obstetrics & gynaecology (start).
- 2010–2018
Canisius Wilhelmina Hospital, Nijmegen
Resident physician & PhD research, obstetrics & gynaecology.
- 2009–2010
Medisch Centrum Alkmaar
Resident physician, obstetrics & gynaecology.
Featured research
Selection of peer-reviewed publications. View the full overview in my portfolio.
Mifepristone followed by misoprostol compared with placebo followed by misoprostol as medical treatment for early pregnancy loss (the Triple M trial): A double-blind placebo-controlled randomised trial.
Hamel C, Coppus S, van den Berg J, Hink E, van Seeters J, van Kesteren P, et al.. EClinicalMedicine, published by The Lancet, 2021 Jan 06.
Mifepristone and misoprostol versus misoprostol alone for uterine evacuation after early pregnancy failure: study protocol for a randomized double blinded placebo-controlled comparison (Triple M Trial).
Van den Berg J, Hamel CC, Snijders MP, Coppus SF, Vandenbussche FP. BMC Pregnancy Childbirth, 2019 Nov 27;19(1):443.
Question or introduction?
I'm happy to reply personally: send a message or connect on LinkedIn.